Cthrc1	NN
lowers	VBZ
pulmonary	JJ
collagen	NN
associated	VBN
with	IN
bleomycin-induced	JJ
fibrosis	NN
and	CC
protects	VBZ
lung	NN
function	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
involves	VBZ
collagen	NN
deposition	NN
that	WDT
results	VBZ
in	IN
a	DT
progressive	JJ
decline	NN
in	IN
lung	NN
function	NN
.	.

This	DT
process	NN
involves	VBZ
activation	NN
of	IN
Smad2/3	NN
by	IN
transforming	VBG
growth	NN
factor	NN
(	(
TGF	NN
)	)
-	:
b	NN
and	CC
Wnt	NN
signaling	NN
pathways	NNS
.	.

Collagen-Triple-Helix-Repeat-Containing-1	NN
(	(
Cthrc1	NN
)	)
protein	NN
inhibits	VBZ
Smad2/3	NN
activation	NN
.	.

To	TO
test	VB
the	DT
hypothesis	NN
that	IN
Cthrc1	NN
limits	NNS
collagen	NN
deposition	NN
and	CC
the	DT
decline	NN
of	IN
lung	NN
function	NN
,	,
Cthrc1	NN
knockout	NN
(	(
Cthrc1	NN
(	(
-	:
/	:
-	:
)	)
)	)
and	CC
wild-type	JJ
mice	NNS
(	(
WT	NN
)	)
received	VBD
intratracheal	JJ
injections	NNS
of	IN
2.5	CD
U/kg	NN
bleomycin	NN
or	CC
saline	NN
.	.

Lungs	NNS
were	VBD
harvested	VBN
after	IN
14	CD
days	NNS
and	CC
Bronchoalveolar	JJ
lavage	NN
(	(
BAL	NN
)	)
TGF-b	NN
,	,
IL1-b	NN
,	,
hydroxyproline	NN
and	CC
lung	NN
compliance	NN
were	VBD
assessed	VBN
.	.

TGF-b	NN
was	VBD
significantly	RB
higher	JJR
in	IN
Cthrc1	NN
(	(
-	:
/	:
-	:
)	)
compared	VBN
to	TO
WT	NNP
(	(
53.45	CD
6.15	CD
ng/mL	NN
vs.	CC
34.48	CD
11.05	CD
)	)
after	IN
saline	NN
injection	NN
.	.

Bleomycin	NN
injection	NN
increased	VBD
TGF-b	NN
in	IN
both	CC
Cthrc1	NN
(	(
-	:
/	:
-	:
)	)
(	(
66.37	CD
8.54	CD
ng/mL	NN
)	)
and	CC
WT	NN
(	(
63.64	CD
8.09	CD
ng/mL	NN
)	)
.	.

Hydroxyproline	NN
was	VBD
significantly	RB
higher	JJR
in	IN
Cthrc1	NN
(	(
-	:
/	:
-	:
)	)
compared	VBN
to	TO
WT	NNP
after	IN
bleomycin-injection	NN
(	(
2.676	CD
0.527	CD
g/mg	NN
vs.	CC
1.889	CD
0.520	CD
,	,
P	NN
=	JJ
0.028	CD
)	)
.	.

Immunohistochemistry	NN
of	IN
Cthrc1	NN
(	(
-	:
/	:
-	:
)	)
lung	NN
sections	NNS
showed	VBD
intracellular	JJ
localization	NN
and	CC
activation	NN
of	IN
b-catenin	NN
Y654	NN
in	IN
areas	NNS
of	IN
tissue	NN
remodeling	NN
that	WDT
was	VBD
not	RB
evident	JJ
in	IN
WT	NNP
Lung	NN
compliance	NN
was	VBD
significantly	RB
reduced	VBN
by	IN
bleomycin	NN
in	IN
Cthrc1	NN
(	(
-	:
/	:
-	:
)	)
but	CC
there	EX
was	VBD
no	DT
effect	NN
in	IN
WT	NNP
animals	NNS
.	.

These	DT
data	NNS
suggest	VBP
Cthrc1	NN
reduces	VBZ
fibrotic	JJ
tissue	NN
formation	NN
in	IN
bleomycin-induced	JJ
lung	NN
fibrosis	NN
and	CC
the	DT
effect	NN
is	VBZ
potent	JJ
enough	RB
to	TO
limit	VB
the	DT
decline	NN
in	IN
lung	NN
function	NN
.	.

We	PRP
conclude	VBP
that	IN
Cthrc1	NN
plays	VBZ
a	DT
protective	JJ
role	NN
,	,
limiting	VBG
collagen	NN
deposition	NN
and	CC
could	MD
form	VB
the	DT
basis	NN
of	IN
a	DT
novel	JJ
therapy	NN
for	IN
pulmonary	JJ
fibrosis	NN
.	.

